Enspryng.com


Keyword Suggestion

Enspryng
Enspryng genentech
Enspryng dosing
Enspryng logo
Enspryng pi
Enspryng gmg
Enspryng myasthenia gravis
Enspryng chpl
Enspryng satralizumab
Enspryng fda label
Enspryng roche
Enspryng package insert
Enspryng start form
Enspryng prescribing information



Domain Informations

Enspryng.com lookup results from whois.1api.net server:
  • Domain created: 2013-09-09T10:36:08Z
  • Domain updated: 2024-06-18T00:52:49Z
  • Domain expires: 2025-09-09T10:36:08Z 1 Year, 53 Days left
  • Website age: 10 Years, 312 Days
  • Registrar Domain ID: 1826617041_DOMAIN_COM-VRSN
  • Registrar Url: http://www.1api.net
  • Registrar WHOIS Server: whois.1api.net
  • Registrar Abuse Contact Email: [email protected]
  • Registrar Abuse Contact Phone: +49.68949396850
  • Name server:
    • ALAN.NS.CLOUDFLARE.COM
    • LARA.NS.CLOUDFLARE.COM

Network
  • inetnum : 104.16.0.0 - 104.31.255.255
  • name : CLOUDFLARENET
  • handle : NET-104-16-0-0-1
  • status : Direct Allocation
  • created : 2010-07-09
  • changed : 2021-07-01
  • desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
  • organization : Cloudflare, Inc.
  • handle : CLOUD14
  • address : Array,San Francisco,CA,94107,US
Abuse
Technical support
Domain Provider Number Of Domains
godaddy.com 286730
namecheap.com 101387
networksolutions.com 69118
tucows.com 52617
publicdomainregistry.com 39120
whois.godaddy.com 32793
enomdomains.com 23825
namesilo.com 21429
domains.google.com 21384
cloudflare.com 20573
gmo.jp 18110
name.com 17601
fastdomain.com 14708
register.com 13495
net.cn 12481
ionos.com 12416
ovh.com 12416
gandi.net 12305
registrar.amazon.com 12111


Host Informations

  • IP address: 104.18.30.32
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Check all domain's dns records


See Web Sites Hosted on 104.18.30.32

Fetching Web Sites Hosted


Site Inspections


Port Scanner (IP: 104.18.30.32)

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080


Spam Check (IP: 104.18.30.32)

 › Dnsbl-1.uceprotect.net:
 › Dnsbl-2.uceprotect.net:
 › Dnsbl-3.uceprotect.net:
 › Dnsbl.dronebl.org:
 › Dnsbl.sorbs.net:
 › Spam.dnsbl.sorbs.net:
 › Bl.spamcop.net:
 › Recent.dnsbl.sorbs.net:
 › All.spamrats.com:
 › B.barracudacentral.org:
 › Bl.blocklist.de:
 › Bl.emailbasura.org:
 › Bl.mailspike.org:
 › Bl.spamcop.net:
 › Cblplus.anti-spam.org.cn:
 › Dnsbl.anticaptcha.net:
 › Ip.v4bl.org:
 › Fnrbl.fast.net:
 › Dnsrbl.swinog.ch:
 › Mail-abuse.blacklist.jippg.org:
 › Singlebl.spamgrouper.com:
 › Spam.abuse.ch:
 › Spamsources.fabel.dk:
 › Virbl.dnsbl.bit.nl:
 › Cbl.abuseat.org:
 › Dnsbl.justspam.org:
 › Zen.spamhaus.org:


Email address with enspryng.com

Found 0 emails of this domain

Recent Searched Sites

Arslankuyumculuk.com (3 seconds ago) / DE

Fm1today.ch (12 seconds ago) / DE

Thurgoodmarshallmustangs.edublogs.org (28 seconds ago) / US

Pole-formation-lda.fr (22 seconds ago) / US

Diamondh2o.com (8 seconds ago) / US

Benestore.it (1 seconds ago) / IT

Choisir-ma-scpi.fr (21 seconds ago) / FR

Drownedinsound.com (3 seconds ago) / US

Zuonline.ch (4 seconds ago) / US

Steg.com (47 seconds ago) / US

Southernriversdental.com (2 seconds ago) / US

Telezueri.ch (15 seconds ago) / CH

We-cts.com (32 seconds ago) / US

Sandbay.ru (27 seconds ago) / RU

Midas-tour.ru (59 seconds ago) / RU

Architectureartdesigns.com (51 seconds ago) / US

Modernvillaco.com (8 seconds ago) / DE

Jw.com (14 seconds ago) / US

Enspryng.com (0 seconds ago) / US

Mtc-dist.com (36 seconds ago) / US

Websites Listing

We found Websites Listing below when search with enspryng.com on Search Engine

ENSPRYNG™ (satralizumab) | Neuromyelitis Optica …

Nausea. inflammation of the stomach lining (gastritis) joint pain (arthralgia) These are not all the possible side effects of ENSPRYNG. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA …

Enspryng.com

Contact a Representative | ENSPRYNG® (satralizumab)

This feature is intended for US healthcare professionals only. Please complete the form below if you would like a Genentech representative to contact you regarding your ENSPRYNG information request. You should receive a response within 2 business days. Your contact information will not be used for any other purpose than for the representative ...

Enspryng-hcp.com

Sign Up for Updates | ENSPRYNG™ (satralizumab)

Upper respiratory tract infection. nausea. inflammation of the stomach lining (gastritis) joint pain (arthralgia) These are not all the possible side effects of ENSPRYNG. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.

Enspryng.com

Clinical Trials & Side Effects | ENSPRYNG™ (satralizumab)

ENSPRYNG may cause serious side effects including: Infections. ENSPRYNG can increase your risk of serious infections some of which can be life-threatening. Talk to your healthcare provider if you are being treated for an infection or call them right away if you think you have signs of an infection, with or without a fever, such as: chills, feeling tired, muscle aches, cough that will not …

Enspryng.com

Log in to Your Account - ENSPRYNG

Upper respiratory tract infection. nausea. inflammation of the stomach lining (gastritis) joint pain (arthralgia) These are not all the possible side effects of ENSPRYNG. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.

Enspryngcopay.com

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

ENSPRYNG (satralizumab) injection is available as a sterile, preservative-free, clear, colourless to slightly yellow solution in a single-use pre-filled syringe (PFS) with needle safety device (NSD). Each ENSPRYNG carton contains one single-use 120 mg pre-filled syringe. Description ENSPRYNG is a recombinant humanized immunoglobulin G2 (IgG2) monoclonal antibody ® …

Rochecanada.com

Sitemap | ENSPRYNG™ (satralizumab)

ENSPRYNG may cause serious side effects including: Infections. ENSPRYNG can increase your risk of serious infections some of which can be life-threatening. Talk to your healthcare provider if you are being treated for an infection or call them right away if you think you have signs of an infection, with or without a fever, such as: chills, feeling tired, muscle aches, cough that will not …

Enspryng.com

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

ENSPRYNG is given by injection under the skin (sub-cutaneously). Always use the entire contents of the syringe during injection. Usual dose: Each injection contains 120 mg of satralizumab. The first injection will be given under the supervision of your healthcare professional. The first three injections are given once every two weeks. These are called …

Rochecanada.com

Submit, Print or Download ENSPRYNG Forms & Documents

Download, view or print ENSPRYNG Access Solutions enrollment forms and other important documents. Submit enrollment forms online. Find sample letters of medical necessity and sample appeal letters. Skip To Main Content. US Patient Site. ENSPRYNG® (satralizumab-mwge) My Patient Solutions® Login Log in to My Patient Solutions® Call (877) 436-3683 Call (877) 436 …

Genentech-access.com

Roche | Enspryng (satralizumab)

ENSPRYNG (satralizumab) is a humanised monoclonal antibody that targets the interleukin-6 (IL-6) receptor. IL-6 is a signalling protein, produced by immune cells in the body, believed to play a key role in the inflammation occurring in people with neuromyelitis optica spectrum disorder (NMOSD), leading to unpredictable and severe relapses. Enspryng is currently approved in …

Roche.com

Please follow these 3 steps to get started: Learn 1.

A representative from Genentech Access Solutions for ENSPRYNG or your doctor’s office will call you to tell you about your coverage, costs and support for your treatment. Please follow these 3 steps to get started: Read “Authorization to Use and Disclose Personal Information”on page 3. 1. Sign and date page 4. Please note you must sign the form to get support for your treatment. 2. …

Genentech-access.com

FDA Approves Treatment for Rare Disease Affecting Optic Nerves, …

2020-08-17  · NMOSD is a rare autoimmune disease of the central nervous system that mainly affects the optic nerves and spinal cord. Enspryng is the third approved treatment for the disorder. “Until last year ...

Fda.gov

Enspryng Approved for NMOSD in European Union

2021-07-01  · The European Commission has approved Enspryng (satralizumab) for the treatment of people, 12 and older, with neuromyelitis optica spectrum disorder (NMOSD) who are positive for antibodies against the aquaporin-4 protein (AQP4-IgG). The approval covers Enspryng for use as a monotherapy (on its own) or in combination with other …

Neuromyelitisnews.com

Enspryng (Satralizumab-mwge Injection for Subcutaneous ... - RxList

2021-05-18  · ENSPRYNG PFS is not made with natural rubber latex. Each ENSPRYNG carton contains one single-dose 120 mg/mL prefilled syringe (NDC 50242-007-01). Storage And Handling. Refrigerate at 2°C to 8°C (36°F to 46°F) in original carton to protect from light. Do not freeze. Do not shake. Prior to administration, ENSPRYNG, if unopened, can be removed from …

Rxlist.com

Enspryng News | Enspryng

2020-08-15  · Roche gets U.S. approval for Enspryng, takes on Alexion's Soliris. Roche gets U.S. approval for Enspryng, takes on Alexion's Soliris. 8/15/2020 3:00:00 PM

Headtopics.com

Roche's ENSPRYNG®️ (satralizumab) approved in Japan for …

2020-06-29  · ENSPRYNG is the first and only approved therapy targeting the interleukin-6 (IL-6) receptor given subcutaneously every four weeks Approval is supported by data demonstrating ENSPRYNG’s robust efficacy, which was well-tolerated with a consistent safety profile, in a broad NMOSD population as a monotherapy and as an add-on therapy

Marketscreener.com


Domains Expiration Date Updated

Site Provider Expiration Date
guardian-transport.com publicdomainregistry.com 1 Year, 25 Days
eksrr.com namesilo.com -1 Years, -351 Days
makiharaayu.com name.com -2 Years, -32 Days
tumpik.com namecheap.com -1 Years, -313 Days
seniorsourcelist.com godaddy.com -2 Years, -103 Days
todo-relojes.com ionos.com -2 Years, -90 Days
ij360mr.com godaddy.com -2 Years, -139 Days
micjp.com gmo.jp -1 Years, -146 Days
etracinc.com ionos.com -2 Years, -7 Days
wearebgc.org whois.godaddy.com 8 Years, 36 Days

    Browser All

    .com4.3M domains   

    .org1M domains   

    .edu40.9K domains   

    .net614.1K domains   

    .gov15.9K domains   

    .us31K domains   

    .ca45K domains   

    .de558.8K domains   

    .uk466K domains   

    .it34.8K domains   

    .au46.6K domains   

    .co34.1K domains   

    .biz13.9K domains   

    .info36.6K domains   

    .fr37.4K domains   

    .eu24.7K domains   

    .ru195.1K domains   

    .ph5.6K domains   

    .in54.2K domains   

    .vn18.9K domains   

    .cn40.2K domains   

    .ro19.4K domains   

    .ch11.7K domains   

    .at10.2K domains   

    Browser All